IRVING, Texas and OTTAWA, Kan., June 16, 2025 /PRNewswire/ -- NorthStar Anesthesia, a leading anesthesia care organization serving hospitals and ambulatory surgery centers nationwide,...
Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ (delandistrogene moxeparvovec), for non-ambulatory Duchenne muscular dystrophy (DMD) patients, irrespective of age, in both clinical and commercial settings. In the commercial setting, non-ambulatory patients should no longer receive Elevidys. In the clinical trial setting, enrolment and dosing of non-ambulatory patients will be immediately paused until additional risk mitigation measures (e.g. immune modulatory treatment) are implemented in the study protocol. Health authorities, investigators and physicians are being informed so that patient care can be quickly adjusted.
RIYADH, Saudi Arabia, June 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, simulation, and immersive technologies across its departments. These technologies have supported KFSHRC to enhance workforce training, clinical care, and operational efficiency.
BOLOGNA, Italy, June 13, 2025 /PRNewswire/ -- Datalogic, a global leader in the automatic data capture and factory automation markets, is proud to announce the...
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard® Prime EPS.
WASHINGTON, June 10, 2025 /PRNewswire/ -- Today, the Anesthesia Patient Safety Foundation (APSF) proudly hosted a Capitol Hill briefing, highlighting the critical need to...
SCOTTSDALE, Ariz., June 10, 2025 /PRNewswire/ -- The NCPDP Foundation is pleased to announce the approval of a $200,000 grant to the CARIN Alliance for...
"Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for...
The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption.
The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption.
OSAKA, Japan, June 10, 2025 /PRNewswire/ -- Linical, a leader in clinical research services, is proud to celebrate its 20th anniversary — a milestone...